86 related articles for article (PubMed ID: 8645335)
1. Distinct responses of mouse hepatic CYP enzymes to corn oil and peroxisome proliferators.
Kojo A; Pellinen P; Juvonen R; Raunio H; Pelkonen O; Pasanen M
Biochem Pharmacol; 1996 May; 51(9):1137-43. PubMed ID: 8645335
[TBL] [Abstract][Full Text] [Related]
2. Tissue and sex-dependent differences in CYP2A activities in hamsters.
Pelkonen P; Lang M; Pasanen M
Arch Toxicol; 1994; 68(7):416-22. PubMed ID: 7979957
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of CYP enzymes in mouse and human liver by pilocarpine.
Kimonen T; Juvonen RO; Alhava E; Pasanen M
Br J Pharmacol; 1995 Feb; 114(4):832-6. PubMed ID: 7773543
[TBL] [Abstract][Full Text] [Related]
4. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
Amacher DE; Beck R; Schomaker SJ; Kenny CV
Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
[TBL] [Abstract][Full Text] [Related]
5. Response of mouse liver coumarin 7-hydroxylase activity to hepatotoxins: dependence on strain and agent and comparison to other monooxygenases.
Pellinen P; Stenbäck F; Rautio A; Pelkonen O; Lang M; Pasanen M
Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):435-43. PubMed ID: 8277979
[TBL] [Abstract][Full Text] [Related]
6. Cerium-induced strain-dependent increase in Cyp2a-4/5 (cytochrome P4502a-4/5) expression in the liver and kidneys of inbred mice.
Salonpää P; Iscan M; Pasanen M; Arvela P; Pelkonen O; Raunio H
Biochem Pharmacol; 1992 Oct; 44(7):1269-74. PubMed ID: 1417950
[TBL] [Abstract][Full Text] [Related]
7. Modification of hepatic cytochrome P450 profile by cocaine-induced hepatotoxicity in DBA/2 mouse.
Pellinen P; Stenbäck F; Raunio H; Pelkonen O; Pasanen M
Eur J Pharmacol; 1994 Nov; 292(1):57-65. PubMed ID: 7867690
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation.
Makowska JM; Anders C; Goldfarb PS; Bonner F; Gibson GG
Biochem Pharmacol; 1990 Sep; 40(5):1083-93. PubMed ID: 2390105
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies on coumarin and testosterone metabolism in mouse and human livers. Differential inhibitions by the anti-P450Coh antibody and metyrapone.
Mäenpää J; Syngelmä T; Honkakoski P; Lang MA; Pelkonen O
Biochem Pharmacol; 1991 Aug; 42(6):1229-35. PubMed ID: 1888331
[TBL] [Abstract][Full Text] [Related]
10. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation.
Sharma RK; Lake BG; Makowski R; Bradshaw T; Earnshaw D; Dale JW; Gibson GG
Eur J Biochem; 1989 Sep; 184(1):69-78. PubMed ID: 2776771
[TBL] [Abstract][Full Text] [Related]
11. Effect of pyrazole, cobalt and phenobarbital on mouse liver cytochrome P-450 2a-4/5 (Cyp2a-4/5) expression.
Hahnemann B; Salonpää P; Pasanen M; Mäenpää J; Honkakoski P; Juvonen R; Lang MA; Pelkonen O; Raunio H
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):289-94. PubMed ID: 1520280
[TBL] [Abstract][Full Text] [Related]
12. Significant interspecies differences in induction profiles of hepatic CYP enzymes by TCDD in bank and field voles.
Murtomaa-Hautala M; Korkalainen M; Pelkonen O; Hegde N; Pohjanvirta R; Huitu O; Henttonen H; Rautio A; Viitala P; Viluksela M
Environ Toxicol Chem; 2012 Mar; 31(3):663-71. PubMed ID: 22213473
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression.
Miller CW; Ntambi JM
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9443-8. PubMed ID: 8790349
[TBL] [Abstract][Full Text] [Related]
14. Induction and inhibition of mouse cytochrome P-450 2B enzymes by musk xylene.
Lehman-McKeeman LD; Johnson DR; Caudill D
Toxicol Appl Pharmacol; 1997 Jan; 142(1):169-77. PubMed ID: 9007046
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures. The effects of model inducers on apoproteins and biotransformation activities.
Wortelboer HM; de Kruif CA; van Iersel AA; Falke HE; Noordhoek J; Blaauboer BJ
Biochem Pharmacol; 1991 Jul; 42(2):381-90. PubMed ID: 1859452
[TBL] [Abstract][Full Text] [Related]
16. Postnatal development of cytochrome P4501A1 and 2B1 in rat lung and liver: effect of aged and diluted sidestream cigarette smoke.
Gebremichael A; Chang AM; Buckpitt AR; Plopper CG; Pinkerton KE
Toxicol Appl Pharmacol; 1995 Dec; 135(2):246-53. PubMed ID: 8545834
[TBL] [Abstract][Full Text] [Related]
17. The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid.
Orton TC; Parker GL
Drug Metab Dispos; 1982; 10(2):110-5. PubMed ID: 6124394
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferators alter the expression of estrogen-metabolizing enzymes.
Corton JC; Bocos C; Moreno ES; Merritt A; Cattley RC; Gustafsson JA
Biochimie; 1997; 79(2-3):151-62. PubMed ID: 9209713
[TBL] [Abstract][Full Text] [Related]
19. Activity of liver microsomal enzymes during the chronic phase of murine schistosomiasis.
Conte FP; Fidalgo-Neto AA; Manhães-Rocha DA; Paumgartten FJ; De-Oliveira AC
Braz J Med Biol Res; 2007 May; 40(5):657-62. PubMed ID: 17464427
[TBL] [Abstract][Full Text] [Related]
20. Biphasic response for hepatic microsomal enzyme induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice.
Shen ES; Guengerich FP; Olson JR
Biochem Pharmacol; 1989 Nov; 38(22):4075-84. PubMed ID: 2512931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
